iiinova — where your digital self keeps evolving

Michael Walsh @lastwalsh.bsky.social · 15/08/2025

Proud to have worked with colleagues and friends around the world on #ACHIEVE. We're disappointed spiro didn't prevent CV death/heart failure hospitalizations, but we've shown it's possible to do publicly funded large RCTs of repurposed meds in ESKD. More to do! www.sciencedirect.com/science/arti...

sciencedirect.com

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

Patients undergoing maintenance dialysis for kidney failure are at substantial risk of cardiovascular morbidity and mortality. We aimed to establish i…

0112

Michael Walsh @lastwalsh.bsky.social · 12/08/2025

Int Society of Nephrology Glomerular Disease fellowships! Our program is not on the small ISN list but can host ISN fellows. We offer glomerular disease clinics, vasculitis clinics, genetics clinics, onconeph clinics and research opportunities. DM if interested! www.theisn.org/in-action/gr...

theisn.org

Fellowships - International Society of Nephrology

044

Michael Walsh @lastwalsh.bsky.social · 30/07/2025

The International Vasculitis Workshop is coming up! One of my favorite meetings for it's sense of community, and possibilities of forming meaningful collaborations (PEXIVAS was hatched in one of them). Call for early career scientists is here mailchi.mp/icmsaust/ivw...

mailchi.mp

Calling Early Career Scientists and Clinicians

021